Please Wait
Applying Filters...
menu
    • menu
    DMF filings rise 4.5% in Q3 2025; China holds lead, India records 20% growth in submissions

    Data Compilation
    #PharmaFlow

    Pipeline Prospector October 2025: Novartis to buy Avidity for US$ 12 bn; FDA approves Bayer’s med to treat hot flashes

    Stock Recap
    #PipelineProspector

    Menu

    Daunorubicin Hydrochloride

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 35,153Xls download

    Filters

    clear-filterReset all filters
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    Log in to access your PharmaMiles and download the data

    Last Updated on PharmaCompass Virtual Booth Country Certificate Holder Certificate No. Substance Issue Date Status Type End Date Substance No.
    31/10/2025 TAPI Technology & API Services
    Israel
    		 TAPI NL B.V. Amsterdam NL CEP 2001-284 - Rev 04 Daunorubicin Hydrochloride 2025-07-24 Valid Chemical 662
    31/10/2025 DZD Heze Pharmaceutical Co Ltd
    China
    		 DZD (HEZE) PHARMACEUTICAL CO., LTD. Heze City CN R1-CEP 2016-253 - Rev 01 Daunorubicin Hydrochloride 2023-02-27 Valid Chemical 662